events
Mark your calendar for November 19-21 and meet us at Fi Europe 2024, Messe Frankfurt, Germany. We look forward to connecting with you at this exciting event!
Learn More >>
Products

Enzymes for Research, Diagnostic and Industrial Use

Products
Online Inquiry

Our Products Cannot Be Used As Medicines Directly For Personal Use.

24 hour
Promise

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.

AAL-993

Cat No.
CEI-0953
Description
A potent and selective inhibitor of VEGFR-1 (IC50=130nM), VEGFR-2 (IC50=23nM) and VEGFR-3 (IC50=18nM). At higher concentrations it inhibits PDGFR (640nM), c-Kit (236nM) and CSF-1R (380nM). Inactive at other kinases such as EGFR, FGFR-1, CDK-1, Tie-2, c-Met, IGF-1R, c-Src and c-Abl. X-ray crystal studies on AAL-993 complexed to the catalytic domain of diphosphorylated VEGFR- 2 indicates that it binds to an inactive conformation of the protein. Cell permeable and active in vivo. Inhibits VEGF-induced angiogenesis (mouse model) (1).
Abbr
AAL-993(VEGFA)
Alias
2-((4-Pyridyl)methyl)amino-N-(3 (trifluoromethyl)phenyl)benzamide
Appearance
Light yellow powder
Product Overview
VEGF inhibitor
CAS No.
269390-77-4
Molecular Weight
371.1
Purity
>98% (TLC); NMR (Conforms)
Synonyms
2-((4-Pyridyl)methyl)amino-N-(3 (trifluoromethyl)phenyl)benzamide
Targets
VEGF
Molecular Formula
C20H16F3N3O
Solubility
May be dissolved in DMSO (>25 mg/ml); or Ethanol (15 mg/ml)

Our Products Cannot Be Used As Medicines Directly For Personal Use.

0
Click unfold / close
Inquiry Basket
Delete selected Quote Check Out
Decide to move out of the shopping cart?
Sure No, Back

Please choose product!

< Go Back
You have already added to buy this product